logo
logo
  • Home
  • RT SOLUTIONS
    • ART-Plan™
      • Annotate
      • SmartFuse
      • MR-Box
      • AdaptBox
  • Neuro Solutions
    • Alzheimer’s Disease
    • Multiple Sclerosis
  • Resources
    • Blog
    • Publications
  • News
  • Careers
  • Contact

AI

4 October 2022

TheraPanacea and Stingray Healthcare collaborate to foster the adoption of AI in radiotherapy

October 4, 2022 - 16:00 CET Stingray Healthcare…

22 December 2021

Biogen & TheraPanacea Announce New Collaboration with the Potential to Advance Digital Health for Personalized Medicine in Neuroscience

December 14, 2021 - 13:00 CET The aim is to develop…

10 February 2021

FDA (510k) clearance for ART-Plan™

TheraPanacea receives FDA (510K) clearance for ART-Plan™:…

9 November 2020

TheraPanacea & Egyptian Ministry of Communications and Information Technology

TheraPanacea & Egypt

12 July 2020

TheraPanacea, Gustave Roussy, AP-HP, ICANS | Institut de cancérologie Strasbourg Europe and GE Healthcare target to improve brain tumor survival through AI-based personalized radiation treatment

Improve brain tumor survival through AI-based personalized…

15 June 2020

New collaborative data bank key to develop AI-based tools for Covid-19 diagnostic and treatment

AI-based tools for Covid-19 diagnostic and treatment

28 August 2018

Predicting the response to immunotherapy with artificial intelligence

Immunotherapy with AI

© 2021 Therapanacea™ | Web design by Domaine-Pack.fr

Privacy Preference Center

Privacy Preferences

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok